NEW YORK, Oct. 29 — Athersys and 3-Dimensional Pharmaceuticals on Monday announced a collaboration to discover and commercialize novel small-molecule pharmaceuticals for disease treatment. 

Terms of the deal call for Cleveland-based Athersys to use its functional genomics technology to complement 3-Dimensional Pharmaceuticals’ drug-development and optimization experience. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.